JUN 18, 2021 6:51 AM PDT

Cancer cell lines are too dissimilar from human cancer cells

A new study finds cultured cancer cells lack genetic similarity to humans. This is concerning because cancer cell lines are often used in drug development efforts. The Johns Hopkins Medicine researchers say that their findings should signal a shift in focus in cancer treatment development from cell lines to genetically engineered mice and tumoroids. They report their results, which describe a computer modeling technique that compares RNA sequences among cancer genomes, in the journal Genome Medicine.

"It may not be a surprise to scientists that cancer cell lines are genetically inferior to other models, but we were surprised that genetically engineered mice and tumoroids performed so very well by comparison," noted lead investigator of the study Patrick Cahan, Ph.D. The differences between a human cell's natural environment and a laboratory growth environment explain the dissimilar genetics of cancer cell lines and human cancer cells. "Once you take tumors out of their natural environment, cell lines start to change," explains Cahan, who is an associate professor of biomedical engineering at The Johns Hopkins University and the Johns Hopkins University School of Medicine.

These conclusions were a result of the new modeling technique called CancerCellNet developed by the research team. With CancerCellNet, the team compared the genetic makeup of RNA sequences with data from a cancer genome atlas and found that genetically engineered mice and tumoroids have RNA sequences most similar to cancer cells. They found this to be true in 4 out of every 5 tumor types they tested, which included breast, lung, and ovarian cancers.

CancerCellNet uses RNA to analyze genetic similarities for multiple reasons. "RNA is a pretty good surrogate for cell type and cell identity, which are key to determining whether lab-developed cells resemble their human counterparts," comments Cahan. "RNA expression data is very standardized and available to researchers, and less subject to technical variation that can confound a study's results. 

The researchers have submitted a patent for CancerCellNet and extend the hope that their findings will help inform current and future cancer research models. They continue to work on making CancerCellNet more reliable and precise. 

Sources: Genome Medicine, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 26, 2021
Cancer
COVID-19 Vaccination Induces Strong Immunity in Cancer Patients
AUG 26, 2021
COVID-19 Vaccination Induces Strong Immunity in Cancer Patients
Cancer patients have a higher risk of developing severe symptoms from a COVID-19 infection.   Many cancer pati ...
AUG 24, 2021
Technology
CRISPR Helps Identify New Therapeutic Target for Leukemia
AUG 24, 2021
CRISPR Helps Identify New Therapeutic Target for Leukemia
Researchers may have found a new druggable target in patients with acute myeloid leukemia (AML), thanks to a CRISPR scre ...
SEP 06, 2021
Drug Discovery & Development
Antibiotics Increase Colon Cancer Risk by 17%
SEP 06, 2021
Antibiotics Increase Colon Cancer Risk by 17%
People who take antibiotics are at an increased risk of developing colon cancer within five to ten years. The research w ...
DEC 02, 2021
Clinical & Molecular DX
Gut Bacteria Slip Into the Pancreas, Cause Cancer
DEC 02, 2021
Gut Bacteria Slip Into the Pancreas, Cause Cancer
  Scientists have connected the dots between bacteria in the digestive system and an increased risk of malignant pa ...
JAN 18, 2022
Clinical & Molecular DX
More Sun, Reduced Breast Cancer Risk
JAN 18, 2022
More Sun, Reduced Breast Cancer Risk
  Besides being a mood booster, spending time in the sun is known to have a number of health benefits. For example, ...
JAN 17, 2022
Cancer
High Fiber Diet Provides a Helpful Boost to Melanoma Treatment
JAN 17, 2022
High Fiber Diet Provides a Helpful Boost to Melanoma Treatment
Immune checkpoint inhibitors (ICIs) have become a promising new treatment for advanced cancers, including melanoma. Immu ...
Loading Comments...